Important Roles Played by TGF-β in Hepatitis B Infection
Overview
Authors
Affiliations
Hepatitis B virus (HBV) which includes, fulminant, acute, chronic, asymptomatic, and occult HBV infection is the most prevalent virus that leads to human liver diseases. Chronic, asymptomatic, and occult infection can induce further sever diseases such as hepatocellular carcinoma (HCC) and cirrhosis of the liver. The underlying mechanisms that allow progression of the prolonged forms of the infection and subsequent HCC or cirrhosis of the liver are yet to be clarified. However, many researchers have suggested that immunological and genetic parameters may play important roles in the etiology of hepatitis B. Transforming growth factor beta (TGF-β) is an important cytokine with dual regulatory functions in the immune system and in the responses against viral infections. However, the pathways and mechanisms controlling these are not fully understood. The crucial roles of TGF-β in the development of Th17 and T regulatory lymphocytes, the main cell types involved in autoimmunity and destructive immune related diseases, have been documented and this provides insights into TGF-β function during hepatitis infection and subsequent HCC and cirrhosis of the liver. Recent findings also confirm that TGF-β directly alters hepatocyte function during hepatitis B, hence, the aim of this review is to address the current data regarding the association and status of TGF-β with hepatitis B infection and its related disorders including HCC and cirrhosis of the liver.
Dumolard L, Gerster T, Chuffart F, Decaens T, Hilleret M, Larrat S Hepatol Commun. 2025; 9(2).
PMID: 39878655 PMC: 11781764. DOI: 10.1097/HC9.0000000000000625.
The impact of β-glucan on the therapeutic outcome of experimental Trichinella spiralis infection.
Elgendy D, Othman A, Eid M, El-Kowrany S, Sallam F, Mohamed D Parasitol Res. 2023; 122(12):2807-2818.
PMID: 37737322 PMC: 10667415. DOI: 10.1007/s00436-023-07964-7.
Insights into the impact of hepatitis B virus on hepatic stellate cell activation.
You H, Wang X, Ma L, Zhang F, Zhang H, Wang Y Cell Commun Signal. 2023; 21(1):70.
PMID: 37041599 PMC: 10088164. DOI: 10.1186/s12964-023-01091-7.
Sarkar N, Chakravarty R, Ganguli S, Singh S, Narayan J, Banerjee A Gastroenterol Hepatol Bed Bench. 2023; 15(4):377-386.
PMID: 36762226 PMC: 9876771. DOI: 10.22037/ghfbb.v15i4.2587.
Genetic dominance of transforming growth factor-β1 polymorphisms in chronic liver disease.
Cai X, Zha H, Yang Z, Du Y, Dai X, Yang B Front Immunol. 2022; 13:1058532.
PMID: 36466817 PMC: 9708878. DOI: 10.3389/fimmu.2022.1058532.